ArticleAdvances in therapy2022

Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting.

Brooke Harrow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.